BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 24970314)

  • 1. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
    J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells.
    Wang J; Wang X; Jiang S; Yuan S; Lin P; Zhang J; Lu Y; Wang Q; Xiong Z; Wu Y; Ren J; Yang H
    J Neurooncol; 2007 Mar; 82(1):11-21. PubMed ID: 16955220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells.
    Tang C; Xue HL; Huang HB; Wang XG
    Neurosci Lett; 2010 Feb; 470(2):126-9. PubMed ID: 20045721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo.
    Chen J; Shi DY; Liu SL; Zhong L
    Oncol Rep; 2012 Feb; 27(2):523-8. PubMed ID: 22038415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential anticancer activity of tanshinone IIA against human breast cancer.
    Wang X; Wei Y; Yuan S; Liu G; Lu Y; Zhang J; Wang W
    Int J Cancer; 2005 Sep; 116(5):799-807. PubMed ID: 15849732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
    Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
    J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction.
    Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X
    Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
    Wang H; Lathia JD; Wu Q; Wang J; Li Z; Heddleston JM; Eyler CE; Elderbroom J; Gallagher J; Schuschu J; MacSwords J; Cao Y; McLendon RE; Wang XF; Hjelmeland AB; Rich JN
    Stem Cells; 2009 Oct; 27(10):2393-404. PubMed ID: 19658188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
    Li GH; Wei H; Lv SQ; Ji H; Wang DL
    Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
    Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
    Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
    Zhou X; Lv L; Tan Y; Zhang Z; Wei S; Xiao S
    Brain Res; 2021 Sep; 1766():147515. PubMed ID: 33984327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
    Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
    Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells.
    Wu N; Liu J; Zhao X; Yan Z; Jiang B; Wang L; Cao S; Shi D; Lin X
    Tumour Biol; 2015 Dec; 36(12):9667-76. PubMed ID: 26150336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.
    Wen N; Guo B; Zheng H; Xu L; Liang H; Wang Q; Wang D; Chen X; Zhang S; Li Y; Zhang L
    Int J Oncol; 2019 Oct; 55(4):879-895. PubMed ID: 31485609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA promotes pulmonary artery smooth muscle cell apoptosis in vitro by inhibiting the JAK2/STAT3 signaling pathway.
    Chen M; Liu Y; Yi D; Wei L; Li Y; Zhang L
    Cell Physiol Biochem; 2014; 33(4):1130-8. PubMed ID: 24733040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
    Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.